Biocon Executive and Leadership Team

Lillian Ramos, the Chief Executive Officer at Biocon, directs the overarching corporate strategy and global market positioning. Overseeing all business units, Ramos ensures alignment with Biocon's mission of providing affordable healthcare solutions worldwide. This leadership role involves driving innovation in biopharmaceutical development and manufacturing, focusing on chronic conditions like diabetes and oncology. By optimizing resource allocation and fostering cross-functional collaboration, Lillian Ramos directly impacts the company's ability to expand its reach across 120+ countries. Ultimately, Ramos secures Biocon's competitive edge in the global biopharma landscape, emphasizing sustainable growth and equitable access to essential medicines.

Revathi Sakamuri, the Principal Chief Executive Officer at Biocon, spearheads critical strategic initiatives and operational excellence across the organization. Sakamuri's leadership ensures the seamless integration of Biocon's diverse business units, including Generics, Biosimilars, Novel Biologics, and Research Services. This executive function involves cultivating strategic partnerships and driving market penetration in key therapeutic areas such as immunology and diabetes. By championing advanced research and development pipelines, Revathi Sakamuri directly contributes to Biocon's position as a global leader in biosimilar insulins and monoclonal antibodies. The focus remains on enhancing patient access to life-saving treatments and reinforcing Biocon's commitment to global health equity.

Shreehas Tambe, the Chief Executive Officer & Managing Director at Biocon, executes the company's strategic vision and operational management. Tambe's dual role encompasses driving growth across all business segments, including Generics, Biosimilars, Novel Biologics, and Research Services. This leadership position involves overseeing the development and manufacturing of high-quality, affordable medicines for chronic conditions, ensuring Biocon's global competitiveness. By fostering a culture of innovation and operational efficiency, Shreehas Tambe directly supports Biocon's expansion into over 120 countries. The objective is to solidify Biocon's standing as a fully integrated global biopharma leader and advance the mission of equitable healthcare access.

Kedar Upadhye, the Chief Financial Officer at Biocon, manages the company's financial health and strategic investment planning. Upadhye oversees all financial operations, including budgeting, forecasting, and capital allocation, ensuring robust fiscal management across Biocon's global operations. This critical function involves optimizing financial performance to support the development and manufacturing of affordable medicines for chronic conditions. By driving financial discipline and exploring strategic funding opportunities, Kedar Upadhye directly enables Biocon's expansion into new markets and therapeutic areas. The focus remains on sustaining profitability while advancing the mission of equitable access to life-saving healthcare solutions worldwide.

Arun Gupta, the Chief Operating Officer at Biocon, directs the company's global manufacturing and supply chain operations. Gupta oversees the efficient production of high-quality, affordable medicines, ensuring compliance with stringent regulatory standards across all facilities. This operational leadership role involves optimizing production processes for generics, biosimilars, and novel biologics, thereby enhancing Biocon's capacity to serve patients in over 120 countries. By driving operational efficiencies and implementing best practices in manufacturing, Arun Gupta directly contributes to Biocon's mission of providing equitable access to critical healthcare solutions. The emphasis is on maintaining product integrity and ensuring reliable delivery of essential treatments.

Mandar Ghatnekar, the Chief Technology Officer at Biocon, leads the company's technological innovation and digital transformation initiatives. Ghatnekar oversees the integration of advanced technologies across research, development, and manufacturing processes, ensuring Biocon remains at the forefront of biopharmaceutical innovation. This executive role involves enhancing data analytics capabilities and cybersecurity measures to protect sensitive information and streamline operations. By championing cutting-edge technological solutions, Mandar Ghatnekar directly supports the development of novel biologics and biosimilars, contributing to Biocon's mission of providing affordable healthcare. The focus is on leveraging technology to accelerate drug discovery and improve patient outcomes globally.

Naveen Narayanan, the Chief Human Resources Officer at Biocon, shapes the company's talent strategy and cultivates a high-performance organizational culture. Narayanan oversees all human resources functions, including talent acquisition, employee development, and compensation, ensuring Biocon attracts and retains top talent globally. This leadership position involves fostering an inclusive work environment that supports Biocon's mission of equitable access to healthcare. By implementing robust HR policies and programs, Naveen Narayanan directly contributes to employee engagement and organizational effectiveness across Biocon's diverse business units. The objective is to build a skilled and motivated workforce capable of driving innovation and achieving strategic business goals.